Skip to content
sellModerate

Orbimed Advisors LLC sold $31M of XTNT

owner at Xtant Medical Holdings, Inc.. 73,114,592 shares at an average of $0.42, traded Apr 10, 2025, filed Apr 14, 2025.

Warning score
57
Value
$31M
73,114,592 shares
Holdings after
0
-131% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $30.7M at market
    +25
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +55.0%, 3m +60.0%, 6m +100.0%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

XTNTOct 12, 2026 · close 0.33
Since filing Apr 14, 2025: -17.5%SPY +46.7% · excess -64.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000947871-25-000392, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 10, 2025SOpen-market sale
Common Stockindirect: See footnotes
-56,004,974$0.42$24M0Apr 14, 2025
Apr 10, 2025SOpen-market sale
Common Stockindirect: See footnotes
-17,109,618$0.42$7.2M0Apr 14, 2025

Related signals

Other insiders at Xtant Medical Holdings, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
25Weak
XTNTbuy
Xtant Medical Holdings, Inc.
Kevin D Brandt
Chief Commercial Officer
$50k
41,670 shares
+5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Orbimed Advisors LLC sold $31M of XTNT | InsiderTell